Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Koc

Showing results (61-70 of 86) with videos related to

Pageof 9
Sort By:
Pharmacogenomics and Personalized Medicine|October 8, 2015
Once-daily dose regimen of ribavirin is interchangeable with a twice-daily dose regimen: randomized open clinical trialJiska M Balk, Guido Rmm Haenen, Özgür M Koc, et al.
Annals of Nuclear Medicine|March 19, 2010
Tumor grade-related thallium-201 uptake in chondrosarcomasG Capa Kaya, Y Demir, S Ozkal, et al.
Journal of Virus Eradication|July 5, 2022
Cascade of care among hepatitis B patients in Maastricht, the Netherlands, 1996 to 2018Eva van Oorschot, Özgür M Koc, Astrid Ml Oude Lashof, et al.
Nigerian Journal of Clinical Practice|May 16, 2019
Which one predicts mortality better? Hemogram and ST elevation myocardial infarctionA Avci, B S Avci, Y Donmez, et al.
Cancer Investigation|July 31, 2007
Soluble vascular endothelial growth factor receptor-1 (sVEGFR-1) is decreased in lung cancer patients showing progression: a pilot studyA Yilmaztepe, E Ulukaya, B Zik, et al.
Transfusion|May 6, 2021
Hepatitis B virus prevalence in first-time blood donors in Flanders, Belgium: Impact of universal vaccination and migrationNiels De Brier, Özgür M Koc, Emmy De Buck, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 9, 2021
Immunogenicity and safety of HBAI20 Hepatitis B vaccine in non-responders: Double-blinded, randomised, controlled phase 2 trialÖzgür M Koc, Philippe de Smedt, Cécile Kremer, et al.
Clinical Nephrology|July 1, 2004
Lessons learned from the catastrophic Marmara earthquake: factors influencing the final outcome of renal victimsM S Sever, E Erek, R Vanholder, et al.
Harm Reduction Journal|October 13, 2021
Hepatitis C reinfection in former and active injecting drug users in BelgiumDana Busschots, Rob Bielen, Özgür M Koc, et al.
Acta Gastro-Enterologica Belgica|July 4, 2021
Uptake of hepatitis C virus screening and treatment in persons under opioid substitution therapy between 2008 and 2013 in BelgiumD Busschots, A Arain, R Bielen, et al.
Pageof 9

Showing results (61-70 of 86) with videos related to

Sort By:
Pageof 9
Pharmacogenomics and Personalized Medicine|October 8, 2015
Once-daily dose regimen of ribavirin is interchangeable with a twice-daily dose regimen: randomized open clinical trialJiska M Balk, Guido Rmm Haenen, Özgür M Koc, et al.
Annals of Nuclear Medicine|March 19, 2010
Tumor grade-related thallium-201 uptake in chondrosarcomasG Capa Kaya, Y Demir, S Ozkal, et al.
Journal of Virus Eradication|July 5, 2022
Cascade of care among hepatitis B patients in Maastricht, the Netherlands, 1996 to 2018Eva van Oorschot, Özgür M Koc, Astrid Ml Oude Lashof, et al.
Nigerian Journal of Clinical Practice|May 16, 2019
Which one predicts mortality better? Hemogram and ST elevation myocardial infarctionA Avci, B S Avci, Y Donmez, et al.
Cancer Investigation|July 31, 2007
Soluble vascular endothelial growth factor receptor-1 (sVEGFR-1) is decreased in lung cancer patients showing progression: a pilot studyA Yilmaztepe, E Ulukaya, B Zik, et al.
Transfusion|May 6, 2021
Hepatitis B virus prevalence in first-time blood donors in Flanders, Belgium: Impact of universal vaccination and migrationNiels De Brier, Özgür M Koc, Emmy De Buck, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 9, 2021
Immunogenicity and safety of HBAI20 Hepatitis B vaccine in non-responders: Double-blinded, randomised, controlled phase 2 trialÖzgür M Koc, Philippe de Smedt, Cécile Kremer, et al.
Clinical Nephrology|July 1, 2004
Lessons learned from the catastrophic Marmara earthquake: factors influencing the final outcome of renal victimsM S Sever, E Erek, R Vanholder, et al.
Harm Reduction Journal|October 13, 2021
Hepatitis C reinfection in former and active injecting drug users in BelgiumDana Busschots, Rob Bielen, Özgür M Koc, et al.
Acta Gastro-Enterologica Belgica|July 4, 2021
Uptake of hepatitis C virus screening and treatment in persons under opioid substitution therapy between 2008 and 2013 in BelgiumD Busschots, A Arain, R Bielen, et al.
Pageof 9